159 related articles for article (PubMed ID: 19424698)
21. Resolution of femoral metaphyseal dysplasia in CINCA syndrome after long-term treatment with interleukin-1 blockade.
Rigante D; Manna R; Verrecchia E; Marrocco R; Leone A
Clin Rheumatol; 2018 Jul; 37(7):2007-2009. PubMed ID: 29766377
[TBL] [Abstract][Full Text] [Related]
22. An unusual phenotype in Muckle-Wells syndrome associated with NLRP3 E311K.
Murphy G; Daly M; O'Sullivan M; Stack J; Rowczenio D; Lachmann H; Shanahan F; Harney S; Hawkins P; Molloy M
Rheumatology (Oxford); 2011 Feb; 50(2):419-20. PubMed ID: 20819795
[No Abstract] [Full Text] [Related]
23. CRYOPYRIN-ASSOCIATED PERIODIC SYNDROME-ASSOCIATED UVEITIS AND PAPILLITIS.
Ma L; Lee S; Montieth A; Stephenson A; Foster CS; Anesi SD
Retin Cases Brief Rep; 2021 Mar; 15(2):149-154. PubMed ID: 30134363
[TBL] [Abstract][Full Text] [Related]
24. Muckle-Wells cryopyrinopathy: complex phenotyping and response to therapy in a new multiplex kindred.
Headley AP; Cordingley F; Hawkins PN; Riminton DS
Inflammation; 2014 Apr; 37(2):396-401. PubMed ID: 24150829
[TBL] [Abstract][Full Text] [Related]
25. Cochlear implantation in a child with CINCA syndrome who also has wide vestibular aqueducts.
Bates JE; Bruce IA; Henderson L; Melling C; Green KM
Cochlear Implants Int; 2012 Aug; 13(3):173-6. PubMed ID: 22333493
[TBL] [Abstract][Full Text] [Related]
26. Severe cryopyrin-associated periodic syndrome first characterized by early childhood-onset sensorineural hearing loss - Case report and literature review.
Hui A; Johnson LB; Greemberg R; Penney L; Ramsey SE
Int J Pediatr Otorhinolaryngol; 2019 May; 120():68-72. PubMed ID: 30772614
[TBL] [Abstract][Full Text] [Related]
27. Anakinra efficacy in a Caucasian patient with renal AA amyloidosis secondary to cryopyrin-associated periodic syndrome.
Aït-Abdesselam T; Lequerré T; Legallicier B; François A; Le Loët X; Vittecoq O
Joint Bone Spine; 2010 Dec; 77(6):616-7. PubMed ID: 20609610
[No Abstract] [Full Text] [Related]
28. Cryopyrin-associated periodic syndrome.
Giat E; Lidar M
Isr Med Assoc J; 2014 Oct; 16(10):659-61. PubMed ID: 25438464
[TBL] [Abstract][Full Text] [Related]
29. Early detection of sensorineural hearing loss in Muckle-Wells-syndrome.
Kuemmerle-Deschner JB; Koitschev A; Tyrrell PN; Plontke SK; Deschner N; Hansmann S; Ummenhofer K; Lohse P; Koitschev C; Benseler SM
Pediatr Rheumatol Online J; 2015 Nov; 13(1):43. PubMed ID: 26531310
[TBL] [Abstract][Full Text] [Related]
30. Sustained response and prevention of damage progression in patients with neonatal-onset multisystem inflammatory disease treated with anakinra: a cohort study to determine three- and five-year outcomes.
Sibley CH; Plass N; Snow J; Wiggs EA; Brewer CC; King KA; Zalewski C; Kim HJ; Bishop R; Hill S; Paul SM; Kicker P; Phillips Z; Dolan JG; Widemann B; Jayaprakash N; Pucino F; Stone DL; Chapelle D; Snyder C; Butman JA; Wesley R; Goldbach-Mansky R
Arthritis Rheum; 2012 Jul; 64(7):2375-86. PubMed ID: 22294344
[TBL] [Abstract][Full Text] [Related]
31. Good response to IL-1beta blockade by anakinra in a 23-year-old CINCA/NOMID patient without mutations in the CIAS1 gene. Cytokine profiles and functional studies.
Hedrich CM; Fiebig B; Sallmann S; Bruck N; Hahn G; Roesler J; Roesen-Wolff A; Heubner G; Gahr M
Scand J Rheumatol; 2008; 37(5):385-9. PubMed ID: 18609262
[TBL] [Abstract][Full Text] [Related]
32. Neonatal-onset multisystem inflammatory disease responsive to interleukin-1beta inhibition.
Goldbach-Mansky R; Dailey NJ; Canna SW; Gelabert A; Jones J; Rubin BI; Kim HJ; Brewer C; Zalewski C; Wiggs E; Hill S; Turner ML; Karp BI; Aksentijevich I; Pucino F; Penzak SR; Haverkamp MH; Stein L; Adams BS; Moore TL; Fuhlbrigge RC; Shaham B; Jarvis JN; O'Neil K; Vehe RK; Beitz LO; Gardner G; Hannan WP; Warren RW; Horn W; Cole JL; Paul SM; Hawkins PN; Pham TH; Snyder C; Wesley RA; Hoffmann SC; Holland SM; Butman JA; Kastner DL
N Engl J Med; 2006 Aug; 355(6):581-92. PubMed ID: 16899778
[TBL] [Abstract][Full Text] [Related]
33. Chorea in a patient with cryopyrin-associated periodic syndrome.
Schwarzbach CJ; Schmitt WH; Szabo K; Bäzner H; Hennerici MG; Blahak C
Neurology; 2016 Jan; 86(3):241-4. PubMed ID: 26683645
[TBL] [Abstract][Full Text] [Related]
34. Anakinra therapy for CINCA syndrome with a novel mutation in exon 4 of the CIAS1 gene.
Matsubayashi T; Sugiura H; Arai T; Oh-Ishi T; Inamo Y
Acta Paediatr; 2006 Feb; 95(2):246-9. PubMed ID: 16449034
[TBL] [Abstract][Full Text] [Related]
35. Endometriosis in the setting of Muckle-Wells syndrome treated with an IL-1β antagonist.
Sasaki-Saito N; Sawada Y; Ohmori S; Omoto D; Haruyama S; Yoshioka M; Nishio D; Nakamura M
Eur J Dermatol; 2017 Aug; 27(4):442-443. PubMed ID: 28508753
[No Abstract] [Full Text] [Related]
36. [Muckle-Wells syndrome caused by a new cryopyrin mutation: effective treatment with interleukin-1 antagonist].
Rameev VV; Kozlovskaia LV; Bogdanova MV
Ter Arkh; 2012; 84(6):53-9. PubMed ID: 22997920
[TBL] [Abstract][Full Text] [Related]
37. Neurologic manifestations of the cryopyrin-associated periodic syndrome.
Kitley JL; Lachmann HJ; Pinto A; Ginsberg L
Neurology; 2010 Apr; 74(16):1267-70. PubMed ID: 20404307
[TBL] [Abstract][Full Text] [Related]
38. Cryopyrin-associated periodic syndrome: an autoinflammatory disease manifested as neutrophilic urticarial dermatosis with additional perieccrine involvement.
Kolivras A; Theunis A; Ferster A; Lipsker D; Sass U; Dussart A; André J
J Cutan Pathol; 2011 Feb; 38(2):202-8. PubMed ID: 21062341
[TBL] [Abstract][Full Text] [Related]
39. [Clinical features of CINCA syndrome: effects and problems of IL-1Ra].
Sugiura H; Matsubayashi T
Nihon Rinsho Meneki Gakkai Kaishi; 2007 Apr; 30(2):108-13. PubMed ID: 17473513
[TBL] [Abstract][Full Text] [Related]
40. Spectrum of clinical features in Muckle-Wells syndrome and response to anakinra.
Hawkins PN; Lachmann HJ; Aganna E; McDermott MF
Arthritis Rheum; 2004 Feb; 50(2):607-12. PubMed ID: 14872505
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]